MedTrace Logo

Effects of Different Wrist Positions in Dorsal Blocking Orthoses After Flexor Tendon Repair

NCT07489235 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-04-02

No results posted yet for this study

Summary

This randomized controlled study aims to compare the effects of three different wrist positions (30° extension, neutral, and 30° flexion) used in dorsal blocking orthoses during early active mobilization after zone I-II flexor tendon repair. A total of 54 patients will be randomly assigned into three groups. All participants will receive the same rehabilitation protocol. Clinical and functional outcomes including total active motion, pain, complications, functional status, and orthosis satisfaction will be evaluated at 6, 8, and 12 weeks by a blinded assessor.

Conditions

  • Flexor Tendon Injury
  • Tendon Injury - Hand

Interventions

DEVICE

3D-Printed Dorsal Blocking Orthosis (wrist 30 degree extension)

Participants will use a 3D-printed dorsal blocking orthosis with the wrist positioned at 30° extension and follow a controlled early active mobilization protocol.

DEVICE

3D-Printed Dorsal Blocking Orthosis (wrist neutral)

Participants will use a 3D-printed dorsal blocking orthosis with the wrist in neutral position and follow the same rehabilitation protocol.

DEVICE

3D-Printed Dorsal Blocking Orthosis (wrist 30 degree flexion)

Participants will use a 3D-printed dorsal blocking orthosis with the wrist positioned at 30° flexion and follow the same rehabilitation protocol.

Sponsors & Collaborators

  • Gazi University Scientific Research Unit

    collaborator UNKNOWN

  • Sedanur Güngör

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-20
Primary Completion
2028-03-06
Completion
2028-08-06

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07489235 on ClinicalTrials.gov